115 related articles for article (PubMed ID: 17652946)
1. Detection of active fraction of glycogen synthase kinase 3beta in cancer cells by nonradioisotopic in vitro kinase assay.
Mai W; Miyashita K; Shakoori A; Zhang B; Yu ZW; Takahashi Y; Motoo Y; Kawakami K; Minamoto T
Oncology; 2006; 71(3-4):297-305. PubMed ID: 17652946
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma.
Miyashita K; Kawakami K; Nakada M; Mai W; Shakoori A; Fujisawa H; Hayashi Y; Hamada J; Minamoto T
Clin Cancer Res; 2009 Feb; 15(3):887-97. PubMed ID: 19188159
[TBL] [Abstract][Full Text] [Related]
3. Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation.
Shakoori A; Ougolkov A; Yu ZW; Zhang B; Modarressi MH; Billadeau DD; Mai M; Takahashi Y; Minamoto T
Biochem Biophys Res Commun; 2005 Sep; 334(4):1365-73. PubMed ID: 16043125
[TBL] [Abstract][Full Text] [Related]
4. Deregulated GSK3{beta} sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase.
Mai W; Kawakami K; Shakoori A; Kyo S; Miyashita K; Yokoi K; Jin M; Shimasaki T; Motoo Y; Minamoto T
Clin Cancer Res; 2009 Nov; 15(22):6810-9. PubMed ID: 19903789
[TBL] [Abstract][Full Text] [Related]
5. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
6. An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta.
Miyashita K; Nakada M; Shakoori A; Ishigaki Y; Shimasaki T; Motoo Y; Kawakami K; Minamoto T
Anticancer Agents Med Chem; 2009 Dec; 9(10):1114-22. PubMed ID: 19925395
[TBL] [Abstract][Full Text] [Related]
7. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glycogen synthase kinase 3beta suppresses coxsackievirus-induced cytopathic effect and apoptosis via stabilization of beta-catenin.
Yuan J; Zhang J; Wong BW; Si X; Wong J; Yang D; Luo H
Cell Death Differ; 2005 Aug; 12(8):1097-106. PubMed ID: 15905881
[TBL] [Abstract][Full Text] [Related]
9. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.
Luo J
Cancer Lett; 2009 Jan; 273(2):194-200. PubMed ID: 18606491
[TBL] [Abstract][Full Text] [Related]
11. Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage.
Chun W; Waldo GS; Johnson GV
J Neurochem; 2007 Dec; 103(6):2529-39. PubMed ID: 17908237
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
[TBL] [Abstract][Full Text] [Related]
13. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
14. Putative role of glycogen as a peripheral biomarker of GSK3β activity.
Frizzo ME
Med Hypotheses; 2013 Sep; 81(3):376-8. PubMed ID: 23809426
[TBL] [Abstract][Full Text] [Related]
15. Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin.
Bergmann MW; Rechner C; Freund C; Baurand A; El Jamali A; Dietz R
J Mol Cell Cardiol; 2004 Sep; 37(3):681-90. PubMed ID: 15350841
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase 3beta induces cell cycle arrest in a cyclin D1-dependent manner in human lung adenocarcinoma cell line A549.
Li JS; Zhu M; Tian D; Wang MX; Wang F; Li NP; Wu RL
Sheng Li Xue Bao; 2007 Apr; 59(2):204-9. PubMed ID: 17437044
[TBL] [Abstract][Full Text] [Related]
17. P2 purinergic receptors signal to glycogen synthase kinase-3beta in astrocytes.
Neary JT; Kang Y
J Neurosci Res; 2006 Aug; 84(3):515-24. PubMed ID: 16810687
[TBL] [Abstract][Full Text] [Related]
18. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis.
Farago M; Dominguez I; Landesman-Bollag E; Xu X; Rosner A; Cardiff RD; Seldin DC
Cancer Res; 2005 Jul; 65(13):5792-801. PubMed ID: 15994955
[TBL] [Abstract][Full Text] [Related]
19. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
